FDA says JLM Nutritionals marketed five Super Naturals supplements as unapproved drugs with disease claims on websites, Amazon, and Facebook.
What happened
In May 2021, FDA reviewed websites supernaturalshealth.com and ibsformula.com, related Amazon pages, and Facebook pages. FDA found claims that Super Naturals IBSolution, Premium Probiotic, Sleep Solution, Joint Solution, and Ultra Omega Fish Oil treat or prevent diseases such as IBS, cancer, heart disease, depression, arthritis, and diabetes. FDA concluded the products are unapproved new drugs and misbranded because they lack adequate directions for use.
What FDA found
FDA says the websites, Amazon pages, and Facebook posts show the products are intended to treat or prevent diseases, which makes them drugs.
FD&C Act section 201(g)(1)(B) [21 U.S.C. 321(g)(1)(B)]FDA says the products are unapproved new drugs because they are not generally recognized as safe and effective for those uses and lack FDA approval.
FD&C Act sections 201(p), 301(d), and 505(a) [21 U.S.C. 321(p), 331(d), 355(a)]FDA says the products are misbranded because they do not have adequate directions for a layperson to use them safely for the claimed disease uses.
FD&C Act section 502(f)(1) [21 U.S.C. 352(f)(1)]; 21 CFR 201.5FDA says introducing or delivering these misbranded drugs into interstate commerce violates the Act.
FD&C Act section 301(a) [21 U.S.C. 331(a)]
What FDA wants
FDA asks the company to notify it in writing within 15 working days of receipt of the letter about steps taken to address the violations, including steps to prevent recurrence and related documentation. If corrective actions cannot be completed in that time, the company must state the reason and the time within which it will do so.
Who should pay attention
- dietary supplement brands that make disease-treatment claims
- online retailers and marketplaces hosting supplement listings
- marketing teams running health-claim content for supplement companies
This is a summary. Read the original letter on fda.gov.